Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral plus topical mesalazine versus topical mesalazine alone for ulcerative proctitis
IRCT20231029059892N1Phase 2Completed
- Sponsor
- Arak University of Medical Sciences
- Start
- Nov 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of Salcrozine in ulcerative proctitis (2 arms), sponsored by Arak University of Medical Sciences. Primary endpoints: Severity of disease activity, Response to treatment and 1 more. Started Nov 2023; status: completed.
02
Drugs
Salcrozine
03
Conditions
ulcerative proctitis
Beyond the preview
Go deeper on IRCT20231029059892N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20231029059892N1.